Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Retinoid X Receptor alpha Antibodies:
anti-Mouse (Murine) Retinoid X Receptor alpha Antibodies:
anti-Rat (Rattus) Retinoid X Receptor alpha Antibodies:
Go to our pre-filtered search.
Human Polyclonal Retinoid X Receptor alpha Primary Antibody for ELISA, WB - ABIN2476395
Stewart, Tuffnell: Cloning the cDNA for horse growth hormone and expression in Escherichia coli. in Journal of molecular endocrinology 1991
Show all 4 Pubmed References
Human Monoclonal Retinoid X Receptor alpha Primary Antibody for EMSA, IP - ABIN2668713
Subbarayan, Mark, Messadeq, Rustin, Chambon, Kastner: RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses. in The Journal of clinical investigation 2000
Show all 2 Pubmed References
Human Polyclonal Retinoid X Receptor alpha Primary Antibody for ELISA, WB - ABIN547352
Claudel, Leibowitz, Fiévet, Tailleux, Wagner, Repa, Torpier, Lobaccaro, Paterniti, Mangelsdorf, Heyman, Auwerx: Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. in Proceedings of the National Academy of Sciences of the United States of America 2001
tRXRalpha was expressed in colorectal tissues from ulcerative colitis patients while tRXRalpha was barely detected in colorectal tissues from healthy individuals.
there is a novel, so far uncharacterized cistromic crosstalk between RXR and STAT6.
the rs11638944:C>G transversion exerts a cis-acting effect on the expression levels of LOXL1, mediated by differential binding of the transcription factor retinoid X receptor alpha and by modulating alternative splicing of LOXL1, eventually leading to reduced levels of LOXL1 mRNA in cells and tissues of risk allele carriers for pseudoexfoliation syndrome
RXRA SNPs are not associated with vitamin D status and multiple sclerosis.
This review analyzes the non-genomic effects of RXRA in normal and tumor cells, and discusses the functional differences based on RXRA protein structure (structure source: the RCSB Protein Data Bank). [review]
The results showed that overexpression of RXRalpha was correlated with unfavorable prognosis, suggesting that RXRalpha may serve as a potential targeted therapeutic marker in the treatment of Esophageal carcinoma (EC).
we found that RXRalpha was upregulated in head and neck squamous cell carcinoma
Single nucleotide polymorphism rs11185644 near the RXRA was significantly associated with 25-Hydroxyvitamin D dose-response.
Variability in the methylation status of the RXRalpha promoter near the EGR transcription factor binding site in newborn cord blood provides controversial epigenetic insights into RXRalpha regulation via EGR proteins.
Here, the authors characterize mutant RXRA, demonstrating it induces enhancer/promoter activity in the context of RXRA/PPAR heterodimers in human bladder cancer cells.
Loss of RXRA is associated with Non-Small Cell Lung Cancer.
These findings unveil RXRalpha as an important cellular factor in modulating HBV infection and may point to a new strategy for host-targeted therapies against HBV.
RXRalpha regulates HBV replication in and minichromosome remodeling.
Findings indicate that Gc globulin (GC) rs16847024, retinoid X receptor gamma (RXRG) rs17429130 and retinoid X receptor alpha (RXRA) rs4917356 were candidate susceptibility markers for gestational diabetes mellitus (GDM) in Chinese females.
retinoic acid receptor beta-retinoic X receptor alpha heterodimer quaternary architecture variable
Immune cell-infiltration is controlled by activated peroxisome proliferator activated receptor gamma (PPARgamma)/retinoid X receptor alpha (RXRalpha) that inhibits expression/secretion of inflammatory cytokines.
Data suggest that the binding of Z-10 to RXRalpha inhibited the interaction of RXRalpha with PML-RARalpha, leading to Z-10's selective induction of PML-RARalpha degradation.
This suggests that hRXRalpha phosphorylation significantly disrupts its nuclear localization, interaction with VDR, intra-nuclear trafficking, and binding to chromatin of the hVDR-hRXR complex.
the expression of CAMP, vitamin D receptor (VDR), and the retinoid X receptor (RXR) isoforms in human skin and gingival tissue biopsies and investigated the signaling pathways involved in 1alpha,25-dihydroxyvitamin D3-induced upregulation of CAMP.
data show that RXRalpha expression is increased in miscarriage in endometrial glands and correlation analysis showed that negative correlation between RXRalpha and PPARgamma disappears in miscarriage. This shift is supposable responsible for the loss of regular function in trophoblast and embryonic tissue.
Transgenic expression of truncated RXRalpha in mice accelerates the development of colitis-associated colon cancer (CAC). The tumorigenic effect of truncated RXRalpha is primarily dependent on its expression in myeloid cells, which results in interleukin-6 (IL-6) induction and STAT3 activation.
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease
Mice lacking the RXR-alpha receptor develop spontaneous melanoma following a single ultraviolet radiation exposure compared to mice with functional RXR-alpha receptor.
The primary aim of the present study was to investigate the potential of Nur77 in Amyloid betainduced neuron apoptosis, and to evaluate the effect of RXRalpha nuclear export inhibition on neuronal apoptosis.
These data suggest that RXRs may be of crucial importance in the mechanism of allergic asthma and that the novel RXR partial agonist NEt-4IB may be a promising candidate for the treatment of allergic airway inflammation and airway hyperresponsiveness in a model of allergic asthma.
The study shows that FXR/RXR regulates Chop expression in a mouse model of steatohepatitis, providing novel insights into pathogenesis of this disorder.
These results suggest a mechanism to establish RXR therapeutic targets with significance in neurodegeneration.
The optimal PPARalpha/RXRalpha heterodimer binding sequence was WAWVTRGGBBAHRGKTYA. The single nucleotide substitution, which reduces binding of RXRalpha to DNA, attenuated PPARalpha-induced transcriptional activation, but this is not always true for PPARalpha.
A change in the heterodimeric partner of Peroxisome Proliferator Activated Receptor-alpha from retinoid X receptor to Silent information regulator 1 is responsible for the impaired fatty acid metabolism and cardiac dysfunction in the failing heart.
interaction of Wnt and RXR-alpha pathways in hepatocyte development and hepatocellular carcinoma
a crucial role of RXRa in suppression of UVB-induced melanomas in the context of driver mutations such as activated CDK4(R24C/R24C) or oncogenic NRAS(Q61K) and altered expression of p53 and PTEN
This uncovered a novel RXR-dependent innate immune regulatory pathway, suggesting that downregulation of RXR expression or RXR antagonist treatment benefits host antiviral response, whereas RXR agonist treatment may increase risk of viral infections.
Data suggest that retinoic acid and GM-CSF-induced retinal dehydrogenase 2 (RALDH2) expression in dendritic cells requires cooperative binding of transcription factor Sp1 via the RA receptor/retinoid X receptor complex to the Aldh1a2 promoter.
The expression and binding of RXRalpha to CYP3A genes in liver was sex-dependent and regulated by growth hormone secretion.
The depletion of retinoic acid and the inhibition of RXRalpha function in hepatic tumors involve more complex mechanisms besides the activation of RAS/ERK pathway.
These observations suggest that beta-apo-13-carotenone regulates RXRalpha transcriptional activity by inducing the formation of the "transcriptionally silent" RXRalpha tetramer.
RXRs modulate post-UVR survival of dermal fibroblasts in a "non-cell autonomous" manner, underscoring their role in immune surveillance, while independently mediating post-UVR melanocyte survival in a "cell autonomous" manner
Drupanin, a component of BGP, is a novel RXR agonist with slight PPARgamma agonistic activity.
two models of cholestasis identify common and injury-specific roles for RXRalpha heterodimers and the functional relevance of an intact RXRalpha-DNA-binding domain in the hepatocytic adaptive cholestatic response
Expression of TauT is differentially regulated by Vitamin D(3) and retinoic acid via formation of VDR and RXR complexes in the nuclei in a cell type-dependent manner.
Retinoid X receptors (RXRs) and retinoic acid receptors (RARs), are nuclear receptors that mediate the biological effects of retinoids by their involvement in retinoic acid-mediated gene activation. These receptors exert their action by binding, as homodimers or heterodimers, to specific sequences in the promoters of target genes and regulating their transcription. The protein encoded by this gene is a member of the steroid and thyroid hormone receptor superfamily of transcriptional regulators.
nuclear receptor subfamily 2 group B member 1
, retinoic acid receptor RXR-alpha
, retinoid X nuclear receptor alpha
, RXR alpha 1
, retinoid X receptor, alpha
, retinoic acid receptor
, retinoid x receptor alpha
, retinoid X receptor alpha
, retinoid X receptor alpha protein
, nuclear receptor subfamily 2 group B member 1-B
, retinoic acid receptor RXR-alpha-B
, retinoid X receptor alpha-B
, retinoid x receptor, gamma